Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Chikungunya
Pharma
FDA signs off on Valneva's chikungunya vaccine Ixchiq
FDA has approved the world’s first chikungunya vaccine, giving a nod to Valneva’s Ixchiq. The accelerated approval is subject to a confirmatory study.
Kevin Dunleavy
Nov 10, 2023 9:55am
Emergent sells 3 vaccines to Bavarian Nordic for $270M-plus
Feb 15, 2023 8:56am
Valneva has poached a vaccine marketing exec from GSK
Nov 17, 2022 10:15am
Themis’ chikungunya vaccine nabs fast FDA review
Feb 26, 2019 11:57am
Valneva looking to buy overlooked vaccines from Big Pharma: CEO
Jan 16, 2019 9:36am
Emergent's new CEO, Valneva and more—News of Note
Jan 9, 2019 8:52am